Abstract:Aim: To discuss two aspects that can be used to improve the adherence to therapy in patients with arterial hypertension (AH): 1) which of the angiotensin II receptor blockers (ARBs) provides the highest adherence rates; 2) how various factors influence adherence rates. Material and methods: An analysis of one of the world's largest clinical practice databases, Truven Health Analytics MarketScan (currently Merative MarketScan), was performed. The analysis included data on patients of both sexes aged 30 to 65 years who had been diagnosed with uncomplicated AH (at least once between March 1, 2012 and January 1, 2018) and prescribed monotherapy with one of ARBs. The exclusion criteria were heart failure and the treatment with two or more ARBs (simultaneously or sequentially) during the treatment period. Ultimately, the study included 717,099 patients with uncomplicated AH, who were divided into four groups based on the prescribed drug: azilsartan (n=4276), candesartan (n=6023), losartan (n=586,857), and valsartan (n=119,943). Adherence to treatment was evaluated by two parameters: duration of continuous therapy and medication possession ratio (MPR). The individual effect of each factor (specific ARB used for therapy, patient gender, age, initial ARB dose, patient co-payment per day of treatment) on the adherence to treatment was assessed using a regression analysis. Results: The adherence to the ARB therapy was generally high. The MPR was the lowest in the azilsartan group and the highest in the candesartan group. However, the parameters that potentially influenced both the MPR and the duration of continuous therapy (patient's gender and age, initial ARB dose, co-payment size) differed significantly between the groups receiving different ARBs. The regression analysis showed that both adherence parameters and the duration of continuous therapy were higher in patients receiving candesartan than in patients receiving azilsartan, losartan or valsartan, when the effect on the adherence of other factors available for study (age, gender, initial dose of the drug, and the absolute size of co-payment for a day of therapy) was excluded. The lowest adherence to therapy was observed in the azilsartan treatment group (p<0.01). Conclusion: The study provided data for comparing the adherence of patients with uncomplicated AH to the therapy with different ARBs. Further study of adherence to treatment will provide additional data that will allow an optimal selection of drugs for the treatment of AH in patients with potentially poor adherence.

A11823 Analysis of Treatment Adherance to Antihypertensive Drugs in Chinese Hypertensive Patients

Analysis of Adherence to Antihypertensive Drugs in Chinese Patients with Hypertension: A Retrospective Analysis Using the China Health Insurance Association Database.

[Study on the Compliance of Antihypertensive Drugs in Patients with Hypertension].

Treatment Adherence As a Mediator of Blood Pressure Control in Chinese Older Adults with Depression.

Effect of medication adherence on blood pressure control and risk factors for antihypertensive medication adherence.

Adherence to antihypertensives in the United States: A comparative meta‐analysis of 23 million patients

Patient Adherence and Duration of Continuous Treatment With Various Arbs in Patients With Uncomplicated Arterial Hypertension in the USA Based on The Analysis of the Truven Health Analytics MarketScan Database

A cross-sectional survey of medication adherence and associated factors for rural patients with hypertension

The influence of value reference point and risk preference on adherence in hypertensive patients in a low-income area of China

[Influencing factors of poor treatment adherence in uncontrolled asthma patients in China].

Patient, family, and community factors associated with medication adherence among people with hypertension or diabetes: A cross-sectional analysis

Antihypertensive medication persistence and adherence among non-Hispanic Asian US patients with hypertension and fee-for-service Medicare health insurance

Adherence to antihypertensive medication and its predictors among non-elderly adults in Japan

The role of ambulatory blood pressure monitoring in enhancing medication adherence among patients with newly diagnosed hypertension: an analysis of the National Health Insurance cohort database

Medication-taking behavior in outpatients with primary hypertension in China:an epidemiological study of 14 capital cities

Determinants of Antihypertensive Adherence among Patients in Beijing: Application of the Health Belief Model.

Influence of Community-based Group Intervention on Treatment Adhesion of Hypertensive Patients

Factors Influencing Medication Adherence in Elderly Patients with Hypertension: A Single Center Study in Western China

Use of Pharmacy Sales Data to Assess Changes in Prescription- and Payment-Related Factors that Promote Adherence to Medications Commonly Used to Treat Hypertension, 2009 and 2014

Analysis of Outpatient Prescriptions of Antihypertensive Drugs

Analysis of Rational Medication for Cardiovascular Diseases in Fujian, China